Steroid Stewardship in COVID-19

  • Gentle Sunder Shrestha Department of Anaesthesiology, Tribhuvan University Teaching Hospital, Maharajgunj, Kathmandu, Nepal
  • Ankit Rimal Department of Anaesthesiology, Tribhuvan University Teaching Hospital, Maharajgunj, Kathmandu, Nepal
DOI: https://doi.org/10.33314/jnhrc.v19i3.3660

Abstract

Corticosteroids have transformed clinical practice in COVID-19 following the publication of the results of the RECOVERY trial. Despite available evidence, there is considerable disparity among physicians in the dose and duration of steroids they prescribe. Steroids have a fragile affiliation in clinical practice with the benefits frequently accompanied by distressing adverse effects. An institutional steroid stewardship program can help all physicians take advantage of what is the only proven therapy of benefit in this global crisis while avoiding its overuse and the numerous adverse effects associated with it.
Keywords: COVID-19; corticosteroids; RECOVERY trial; steroid stewardship

Published
2021-12-15
How to Cite
ShresthaG. S., & RimalA. (2021). Steroid Stewardship in COVID-19. Journal of Nepal Health Research Council, 19(03), 631-634. https://doi.org/10.33314/jnhrc.v19i3.3660
Issue
Vol. 19 No. 03 (2021): Vol 19 No 3 Issue 52 Jul-Sep 2021
Section
Short Communication

Copyright (c) 2021 Gentle Sunder Shrestha, Ankit Rimal

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Journal of Nepal Health Research Council JNHRC allows to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. Copyright is retained by author. The JNHRC work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).